Preparation of 5-fluorouracil microparticles and 5-fluorouracil/poly(L-lactide) composites by a supercritical CO2 antisolvent process

被引:20
|
作者
Cuadra, Isaac A. [1 ]
Zahran, Fouad [1 ,2 ]
Martin, Daniel [1 ]
Cabanas, Albertina [1 ]
Pando, Concepcion [1 ]
机构
[1] Univ Complutense, Dept Quim Fis, E-28040 Madrid, Spain
[2] Helwan Univ, Fac Sci, Chem Dept, El Cairo, Egypt
来源
关键词
5-Fluorouracil; Supercritical CO2; Poly(L-lactide); Supercritical antisolvent; Controlled delivery; CARBON-DIOXIDE; DRUG-DELIVERY; RELEASE; FLUIDS; COPRECIPITATION; NANOPARTICLES; MECHANISMS; ENCAPSULATION; FUNDAMENTALS; SOLUBILITY;
D O I
10.1016/j.supflu.2018.07.027
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Microparticles of the anticancer drug 5-fluorouracil (5-Fu) were successfully prepared by supercritical antisolvent (SAS) precipitation using dimethylsulfoxide as solvent. The effect on particle size (PS) of the experiment parameters was studied. The conditions of temperature and pressure were the most important factors. Mean PS values ranged from 220 to 670 nm. Using as solvent a dimethylsulftudde + dichloromethane mixture, the SAS process was also used to obtain composite particles in which 5-Fu crystals are coated by a layer of poly(L-lactide) spheres. The particle morphology was studied by SEM. Other characterization included powder X-ray diffraction, DSC, TGA, and the measurement of the dissolution profiles. The composite particles were shown to provide a controlled delivery system.
引用
收藏
页码:64 / 71
页数:8
相关论文
共 50 条
  • [21] L-Cysteine conjugated poly L-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo
    Mishra, Brijeshkunvar J.
    Kaul, Ankur
    Trivedi, Piyush
    DRUG DELIVERY, 2015, 22 (02) : 214 - 222
  • [22] PREPARATION AND STABILITY OF LIPOSOMES CONTAINING 5-FLUOROURACIL
    OZER, AY
    TALSMA, H
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 55 (2-3) : 185 - 191
  • [23] The preparation and characterization of 5-fluorouracil loaded microspheres
    Li, Hang
    Yuan, Hua
    Zhong, Qian
    Ren, Jie
    Gongneng Cailiao/Journal of Functional Materials, 2007, 38 (02): : 298 - 301
  • [24] Solubilities of 5-fluorouracil and ß-estradiol in supercritical carbon dioxide
    Guney, O
    Akgerman, A
    JOURNAL OF CHEMICAL AND ENGINEERING DATA, 2000, 45 (06): : 1049 - 1052
  • [25] Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2′-tetrahydrofuryl)-5-fluorouracil
    Ho, DH
    Pazdur, R
    Covington, W
    Brown, N
    Huo, YY
    Lassere, Y
    Kuritani, J
    CLINICAL CANCER RESEARCH, 1998, 4 (09) : 2085 - 2088
  • [26] METABOLISM OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL TO 5-FLUOROURACIL IN PARTIALLY HEPATECTOMIZED RATS
    MAEHARA, Y
    TAKAHASHI, I
    YOSHIDA, M
    EMI, Y
    BABA, H
    KUSUMOTO, H
    KOHNOE, S
    SUGIMACHI, K
    ANTI-CANCER DRUGS, 1992, 3 (02) : 117 - 120
  • [27] Fabrication and Use of Poly(D,L-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil
    Leelakanok, Nattawut
    Geary, Sean
    Salem, Aliasger
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (02) : 513 - 528
  • [28] Poly(butylcyanoacrylate) nanoparticles for topical delivery of 5-fluorouracil
    Simeonova, M
    Velichkova, R
    Ivanova, G
    Enchev, V
    Abrahams, I
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 263 (1-2) : 133 - 140
  • [29] Microencapsulation of puerarin nanoparticles by poly(L-lactide) in a supercritical CO2 process
    Chen, Ai-Zheng
    Li, Yi
    Chau, Foo-Tim
    Lau, Tsui-Yan
    Hu, Jun-Yan
    Zhao, Zheng
    Mok, Daniel Kam-wah
    ACTA BIOMATERIALIA, 2009, 5 (08) : 2913 - 2919
  • [30] Incorporation of novel 1-alkylcarbonyloxymethyl prodrugs of 5-fluorouracil into poly(lactide-co-glycolide) nanoparticles
    McCarron, P. A.
    Hall, M.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 348 (1-2) : 115 - 124